The Herald has contacted Haddleton for comment.<\/p>\n
Helius Therapeutics was an early leader in the medical cannabis sector but has now gone into voluntary administration.<\/p>\n
Taylor said the company\u2019s priority is to support staff and ensure patients continue to receive care through the clinic network.<\/p>\n
\u201cMost importantly, I want to thank the great people who have worked at Helius Therapeutics. Their commitment to patients, innovation and quality has been remarkable, and I\u2019m grateful for everything they have contributed.<\/p>\n
\u201cWhile this is a disappointing moment, the need for safe, affordable access to medical cannabis remains strong, and the progress made by this industry will continue to benefit patients in the years ahead.\u201d<\/p>\n
Up in smoke<\/p>\n
Millions of dollars of investor capital have gone up in smoke over the past couple of years as medicinal cannabis companies struggle to get off the ground in New Zealand.<\/p>\n
Cannasouth<\/a>, the first medicinal cannabis company to list on the NZX in 2019, went into voluntary administration in March 2024 and delisted from the NZX later that year.<\/p>\n In February last year, Aether Pacific Pharmaceuticals<\/a>, formerly known as Medical Kiwi, entered liquidation. <\/p>\n Company debts totalled $8.7m, according to an initial liquidator\u2019s report.<\/p>\n